Comparison of pirarubicin-based versus gemcitabine-docetaxel chemotherapy for relapsed and refractory osteosarcoma
International Journal of Clinical Oncology,  Clinical Article

He A et al. – Pirarubicin–based chemotherapy was comparable with gemcitabine–docetaxel as a second–line treatment for relapsed and refractory osteosarcoma, and it even seemed to show greater efficacy, with milder toxicity.

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

    Currently, there are no available articles.

Your Unread Messages in Nurse Practitioner

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Nurse Practitioner Articles

Indexed Journals in Nurse Practitioner: Journal of the American Academy of Nurse Practitioners, Holistic Nursing Practicemore